- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04302285
Impact of Single Exercise Session Conducted Prior to PKU Type Meal on Appetite Hormones and Energy Intake
Impact of Single Exercise Session Conducted Prior to Phenylketonuria (PKU) Type Meal on Appetite Hormones, Metabolic Rate, Fat Oxidation and Energy Intake
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants of the study were essentially healthy men with body mass index (BMI) ≤29 kg/m2 and aged between 22-35 years, recruited by advertisements and word of mouth. Study participants were required to be non-smokers, to have stable body weight for one month prior to study enrolment, and were not taking any medication, nutritional supplement or being on a special diet. Exclusion criteria included chronic illness, eating disorder and history of gastrointestinal operations which could interfere with the results of the study. Written informed consent were obtained prior commencing the study. The Ethics Committee of the collage of Medical Veterinary and Life Sciences, Glasgow University approved the study.
Preliminary session
Before joining the study, preliminary session was conducted for ~3 hours. Participants were informed to come to the metabolic research unit at New Lister Building, Glasgow Royal Infirmary to completed physical activity readiness questionnaire (PARQ), healthy screening questionnaire and International physical activity questionnaire. Only participants at light or moderate of physical activity level, answered "no" to all questions in PARQ and were in generally good health were eligible to complete the preliminary session. Subsequently, height and body mass were measured and a ~30 min submaximal exercise test was conducted at gradually increasing inclines. After 4 minutes of warming up period (3.5 km/hr and 0% incline), participants were walking at a constant speed of 6 km/hr with incline being increased by 2% every 4 min. The test was terminated when the heart rate (HR) reached 85% of maximal HR (HRmax) defined as 220 - age in years. During the test, participants were wearing a HR monitor and a face mask (to measure rate of oxygen consumption (V̇O2) and rate of carbon dioxide production (V̇CO2)). The HR monitor and the mask were both connected to the indirect calorimetry machine (Quark RMR®, COSMED, Italy). The obtained data was used to predict maximal oxygen consumption (V̇O2max) which was achieved by extrapolation of the HR against V̇O2 in order to calculate workload corresponds to 60% of V̇O2max.
Experimental trials
A randomisation scheme was generated using GraphPad Software 2018© to allocate participants to the experimental trials. Trials were marked as Control and Exercise by the researcher. Each participant started first trial according to allocated trial randomization. On the morning of each experiment trial, participants reported to the metabolic research unit between 08:00 and 09:00 after an overnight fast. Height, body mass and resting metabolic rate (RMR) were measured. A cannula was introduced into an antecubital vein and after an interval of 10 min, a baseline blood sample was obtained. Subsequently, an appetite questionnaire was completed. Participants were then asked to either resting (Control trial) or exercising (Exercise trial) for one hour. The Exercise trials were conducted under controlled laboratory conditions. Participants were exercising on the treadmill (Trackmaster Treadmills, Full Vision, Inc., Kansas, USA) at speed and grade corresponding to 60% of their V̇O2max. Participants were wearing a HR monitor and a face mask while exercising, connected to indirect calorimetry equipment (Quark RMR®, COSMED, Italy). V̇O2 and V̇CO2 in the inspired and expired air were measured to calculate fat and CHO oxidation and rate of physical activity energy expenditure (PAEE) by using indirect calorimetry equations described by Frayn and Macdonald (1997).
Subsequently, participants in both trials were presented to a standard isocaloric PKU type meal at 120 min. PKU meals in Exercise and Control trials were matched for weight content and macronutrient composition. Participants were asked to consume the entire meal within 20 min. Appetite questionnaires were obtained and blood samples were collected at 30, 60, 90 and 120 pre-meal, 150, 180, 210, 240 and 300 min post-meal. Metabolic rate was measured every 30 min after each blood sample. After the completion of the last measurement, the participants were presented with an ad libitum buffet test meal which used to assess, under laboratory conditions, the spontaneous macronutrient and energy intake (EI). After completion of each trial, participants required to record their EI for the remainder of the experimental day using a self-recorded food diary. Water was available throughout the trials, but intake was replicated in the second trial and consumption time was matched. During the two days before the first trial, participants weighed and recorded all foods and drinks consumed and were asked to replicate this intake during the two days preceding the second trial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Glasgow, United Kingdom
- Univesrity of Glasgow
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy men with
- Body mass index (BMI) ≤29 kg/m2
- Aged 22-35 years
- Stable body weight for one month prior to study enrolment, and were
- Not taking any medication, nutritional supplement or being on a special diet.
Exclusion Criteria:
- Smokers
- Chronic illness
- Eating disorder
- History of gastrointestinal operations which could interfere with the results of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Exercise trial
In this trial, participants were asked to exercise for one hour under controlled laboratory conditions.
Participants were exercising on the treadmill at speed and grade corresponding to 60% of their V̇O2max.
Participants were wearing a HR monitor and a face mask while exercising, connected to indirect calorimetry equipment.
Appetite questionnaires were obtained, and blood samples were collected at 30, 60, 90 and 120 pre-meal, 150, 180, 210, 240 and 300 min post-meal.
Metabolic rate was measured every 30 min after each blood sample.
Participants were presented to a standard isocaloric PKU type meal at 120 min.
After the completion of the last measurement, the participants were presented with an ad libitum buffet test meal.
|
|
EXPERIMENTAL: Control trial
In this trial, participants were asked to rest for one hour.
Appetite questionnaires were obtained, and blood samples were collected at 30, 60, 90 and 120 pre-meal, 150, 180, 210, 240 and 300 min post-meal.
Metabolic rate was measured every 30 min after each blood sample.
Participants were presented to a standard isocaloric PKU type meal at 120 min.
After the completion of the last measurement, the participants were presented with an ad libitum buffet test meal.
|
PKU type meal was based on PKU special low protein foods (50% of total energy intake), natural free protein foods (37%) and protein substitute (13%).
Calories provided in breakfast were 600 kcal and were not based on individual dietary requirement.
65% of total energy intake was provided from carbohydrate, 13% from protein and 22% from fat.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peptide YY (PYY)
Time Frame: 300 minutes through study completion, an average of 12 days
|
Changes in plasma concentration of fasting and postprandial PYY were measured during the Exercise and Control trials.
|
300 minutes through study completion, an average of 12 days
|
Glucagon-like peptide-1 (GLP-1)
Time Frame: 300 minutes through study completion, an average of 12 days
|
Changes in plasma concentration of fasting and postprandial GLP-1 were measured during the Exercise and Control trials.
|
300 minutes through study completion, an average of 12 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective appetite score
Time Frame: 300 minutes through study completion, an average of 12 days
|
Appetite scores during Exercise and Control trials were assessed using a 100-mm Visual Analog Scale, with 0 mm meaning one and 100 mm another extreme of hunger, desire to eat, fullness, prospective food consumption, and satiety.
|
300 minutes through study completion, an average of 12 days
|
Dietary intake
Time Frame: 24 hours through study completion, an average of 12 days
|
Energy and macronutrient intake during Exercise and Control trials was analysed using WinDiets software based on food composition tables.
|
24 hours through study completion, an average of 12 days
|
Diet induced thermogenesis
Time Frame: 300 minutes through study completion, an average of 12 days
|
Metabolic rate measured during Exercise and Control trials by means of indirect calorimetry
|
300 minutes through study completion, an average of 12 days
|
Growth differentiation factor 15 (GDF-15)
Time Frame: 300 minutes through study completion, an average of 12 days
|
Changes in plasma concentration of fasting and postprandial GDF-15 were measured during the Exercise and Control trials.
|
300 minutes through study completion, an average of 12 days
|
Fat oxidation
Time Frame: 300 minutes through study completion, an average of 12 days
|
Rate of fat oxidation during Exercise and Control trials was measured by means of indirect calorimetry
|
300 minutes through study completion, an average of 12 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 200170151
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on PKU type meal and Exercise
-
University of SaskatchewanHeart and Stroke Foundation of CanadaCompletedHyperlipidemiaCanada
-
Clinical Nutrition Research Centre, SingaporeNanyang Technological UniversityUnknown
-
Nottingham Trent UniversityLoughborough UniversityCompletedObesity | Metabolic SyndromeUnited Kingdom
-
Clinical Nutrition Research Centre, SingaporeCompletedGlycaemic ResponseSingapore
-
University of Missouri-ColumbiaCompletedType 2 Diabetes
-
Steno Diabetes Center CopenhagenSwansea UniversityCompleted
-
University of GrazMedical University of GrazRecruitingType 1 Diabetes | Pregnancy in DiabeticAustria
-
APR Applied Pharma Research s.a.RecruitingPhenylketonuriasUnited Kingdom
-
University of VirginiaTerminatedExercise | Ketogenic DietUnited States
-
Federal University of Rio Grande do SulCompletedSedentary Lifestyle | Dyslipidemias | Lipid Metabolism Disorders | Carbohydrate Inducible Hyperlipemia